Boom in weight-loss drugs could lead to drop in beer sales, Heineken warns British pubs
World’s second largest brewer says use of drugs such as Wegovy can reduce desire to drink alcoholHeineken has warned British bars and pubs that the boom in popularity of weight-loss drugs could lead to a fall in sales of beer and cider.The world’s second largest brewer sent a presentation to British hospitality customers earlier this month warning that GLP-1 use – led by Ozempic and Wegovy – can reduce the desire to drink alcohol, which could lead to “fullness and fewer serves” of pints in pubs and bars. Continue reading...
Countries concerned
Read the original article — The Guardian — Europe
Items are taken from public sources: only the headline and summary appear here, the full article stays on the source’s own site.
This subject deserves more than a headline
Comments are just above. To go further: a debate on the forum, or a signed op-ed.A question the subject raises for you. Debated together.
Open a debateA stand the subject inspires in you. A signed text, published on its own.
Write an op-edNo tribune written in reply yet.
No comments yet — be the first
Sign in to comment. Sign in